Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599765 · ClinicalTrials.gov registry record · Phase 2
Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
A Phase 2 study of Oligometastatic Malignant Solid Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 380
- Enrollment target
- 12
- Study locations
NCT03599765: Active Phase 2 study of Oligometastatic Malignant Solid Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT03599765 is a Phase 2 study of Oligometastatic Malignant Solid Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 380 participants. The trial reports 12 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03599765, a Phase 2 study of Oligometastatic Malignant Solid Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 380 participants
- Enrollment target
- 12
- Study locations
Study Summary
This phase II trial studies how well systemic therapy with or without local consolidative therapy work in treating patients with solid tumor that has spread to 1 site of other places in the body. Treatment with up-front local consolidative therapy may be better in helping to control the disease.
Conditions Studied
Interventions
- OTHER Best Practice
- PROCEDURE Local Consolidation Therapy
Study Locations (12)
Texas
- M D Anderson Cancer Center - Houston
- MD Anderson in Katy - Houston
- MD Anderson League City - Nassau Bay
- University of Texas Health Science Center at San Antonio - San Antonio
- MD Anderson in Sugar Land - Sugar Land
- MD Anderson in The Woodlands - The Woodlands
Arizona
- Banner MD Anderson Cancer Center - Gilbert
Arkansas
- Baptist Health Medical Center - Little Rock
Hawaii
- Queen's Medical Center - Honolulu
Michigan
- Community Health Center - Coldwater
New Jersey
- Cooper Hospital University Medical Center - Camden
Ohio
- OhioHealth Mansfield Hospital - Mansfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2018-07-31 |
| Est. Completion | 2029-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03599765
The ClinicalTrials.gov registry entry for NCT03599765 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oligometastatic Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Best Practice is the first listed.
NCT03599765 reports 12 study locations spanning 7 distinct geographic areas - top geographies include Texas, Arizona, Arkansas.
Frequently Asked Questions
What is clinical trial NCT03599765 about?
NCT03599765 is a clinical study titled "Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor". This phase II trial studies how well systemic therapy with or without local consolidative therapy work in treating patients with solid tumor that has spread to 1 site of other places in the body. Treatment with up-front local consolidative therapy may be better in helping to control the disease.
What is the current status of trial NCT03599765?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 380 participants. The study started on 2018-07-31. Estimated completion is 2029-12-31.
What conditions does trial NCT03599765 study?
This clinical trial studies the following conditions: Oligometastatic Malignant Solid Neoplasm.
What interventions are being tested in trial NCT03599765?
The interventions under investigation include: Best Practice (OTHER), Local Consolidation Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT03599765?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03599765 being conducted?
This trial has 12 study locations across Arizona, Arkansas, Hawaii, Michigan, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Oligometastatic Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.